← Research index  ·  Disorder page  ·  Source YAML

Cross-provider research synthesis

Bartter Syndrome

MONDO:0015231 Curated 2026-07-04T00:00:00Z 9 harmonized findings
falcon · 51 citations openscientist · 40 citations
Concordant asserts the finding Partial supports a weaker/qualified form Contradictory conflicts with it Silent does not address it

Harmonized findings

Bartter syndrome is an inherited salt-losing renal tubulopathy caused by defective NaCl reabsorption in the thick ascending limb (TAL) of the loop of Henle, producing hypokalemic hypochloremic metabolic alkalosis with hyperreninemic secondary hyperaldosteronism and characteristically normal-to-low blood pressure.

UNANIMOUS INTEGRATED
pathophysiologyphenotype
ProviderStanceScoreEvidence
falcon CONCORDANT 93% characterized by polyuria/failure to thrive, hypokalemia, metabolic alkalosis, hyperreninemia and hyperaldosteronism; antenatal forms often show polyhydramnios and prematurity
Falcon defines BS as a TAL salt-wasting tubulopathy with the same core biochemical/clinical profile (hypokalemia, metabolic alkalosis, hyperreninemia, hyperaldosteronism).
DOI:10.3389/fmed.2023.1099840
openscientist CONCORDANT 95% The hallmark biochemical profile consists of hypokalemic hypochloremic metabolic alkalosis, secondary hyperaldosteronism, and normal-to-low blood pressure.
OpenScientist states the identical hallmark triad and adds the normal-to-low blood pressure feature explicitly.
PMID:42042082

COX-2-driven PGE2 overproduction in the macula densa is a central mechanistic node linking TAL salt wasting to hyperreninemia, and provides the rationale for prostaglandin-inhibitor (indomethacin/NSAID) therapy.

MAJORITY INTEGRATED
pathophysiologytreatment
ProviderStanceScoreEvidence
openscientist CONCORDANT 92% COX-2 expression in the macula densa drives PGE₂ overproduction, which is the proximate cause of hyperreninemia
OpenScientist details the COX-2/PGE2 macula-densa axis as the proximate cause of hyperreninemia (r = 0.86 correlation), the mechanistic basis for indomethacin.
PMID:12081585, PMID:929154
falcon PARTIAL 55% (e.g., indomethacin/ibuprofen/celecoxib) to counter prostaglandin-mediated renal losses; a 2023 cohort found no clear outcome differences among NSAID types used.
Falcon endorses prostaglandin-mediated pathology and NSAID/COX-inhibitor therapy but does not develop the specific COX-2 / macula-densa / PGE2-hyperreninemia mechanism, so it supports only part of the claim.
DOI:10.3389/fmed.2023.1099840

The contemporary Bartter syndrome spectrum is defined by five core disease genes — SLC12A1 (NKCC2), KCNJ1 (ROMK), CLCNKB (ClC-Kb), BSND (barttin), and MAGED2 — all encoding TAL ion-transport machinery, inherited autosomal recessively except the X-linked MAGED2 transient form.

UNANIMOUS INTEGRATED
genetic_factorgene_function
ProviderStanceScoreEvidence
falcon CONCORDANT 90% SLC12A1, KCNJ1, CLCNKB, CLCNKA, BSND, MAGED2
Falcon maps the same causal genes to TAL transporter functions and states types 1-4 are autosomal recessive while MAGED2-related transient antenatal BS is X-linked.
DOI:10.3390/medicina59091638
openscientist CONCORDANT 95% Current evidence supports SLC12A1, KCNJ1, CLCNKB, BSND, and MAGED2 as the core disease genes within the contemporary BS spectrum, with MAGED2 causing a distinct X-linked transient antenatal form
OpenScientist gives the identical five-gene classification and notes the reclassification of CASR gain-of-function variants out of the BS spectrum.
PMID:42042082

In the most severe (MAGED2/type V) prenatal form, NKCC2 fails to reach the apical TAL membrane because of endoplasmic-reticulum retention and ER-associated degradation (ERAD), implicating protein quality control in BS pathogenesis.

UNANIMOUS INTEGRATED
pathophysiologygene_function
ProviderStanceScoreEvidence
falcon CONCORDANT 88% ER retention/ERAD can prevent NKCC2 detection at the apical membrane in severe prenatal disease contexts
Falcon highlights ER export/ERAD of NKCC2 as a rate-limiting quality-control node in severe prenatal disease.
DOI:10.3390/cells13100818
openscientist CONCORDANT 90% NKCC2 is not detectable in the apical membrane of thick ascending limb (TAL) cells due to ER retention and ER-associated degradation (ERAD) mechanisms
OpenScientist independently attributes the type-5 defect to ER retention and ERAD of NKCC2, matching Falcon's mechanism.
PMID:38786040

The MAGED2 X-linked form is a transient antenatal Bartter syndrome: it presents as the most severe perinatal phenotype (early severe polyhydramnios, extreme prematurity, high perinatal mortality) yet typically resolves spontaneously in survivors.

UNANIMOUS INTEGRATED
genetic_factorprognosisphenotype
ProviderStanceScoreEvidence
falcon CONCORDANT 85% X-linked; mostly affects males, though skewed X-inactivation can make heterozygous females symptomatic
Falcon describes the X-linked MAGED2 form as severe fetal disease with high perinatal risk but transient, spontaneously recovering electrolyte abnormalities in survivors.
DOI:10.1186/s12920-024-01797-8
openscientist CONCORDANT 90% 32% perinatal fatality rate; 27% spontaneous resolution; 41% persistent complications
OpenScientist quantifies the paradoxical MAGED2 outcome (32% perinatal fatality but frequent spontaneous resolution), concordant with Falcon's transient-severe framing.
PMID:39036894

Management is symptomatic and lifelong: COX inhibition (indomethacin/NSAIDs) plus potassium (and sodium) electrolyte supplementation to correct the salt-wasting and electrolyte/acid-base derangements.

UNANIMOUS INTEGRATED
treatment
ProviderStanceScoreEvidence
falcon CONCORDANT 90% received potassium chloride supplementation and
Falcon documents the standard-of-care combination (KCl supplementation in 94% and potassium-sparing agents in the Korean cohort, alongside NSAID therapy).
DOI:10.3389/fmed.2023.1099840
openscientist CONCORDANT 92% Corrects hyperreninemia, improves electrolyte balance, promotes growth
OpenScientist names indomethacin first-line (correcting hyperreninemia and promoting growth) with electrolyte replacement, matching Falcon's treatment framework.
PMID:40262923

Chronic kidney disease is a major long-term complication of Bartter syndrome, developing in a substantial minority of patients, with BS type I and lower gestational age as risk factors.

MAJORITY INTEGRATED
prognosis
ProviderStanceScoreEvidence
openscientist CONCORDANT 90% ~30% of BS patients develop CKD; BS Type I and lower gestational age are risk factors
OpenScientist reports the ~30% aggregate CKD rate and the type-I / low gestational-age risk factors.
PMID:35628451
falcon PARTIAL 60% even with treatment, 2023 multicenter cohort evidence shows high residual rates of growth impairment (41%) and measurable CKD risk (11%)
Falcon agrees CKD is a real long-term risk but reports a lower cohort-specific figure (11% G3-G5 in the Korean cohort) than OpenScientist's ~30% aggregate — a quantitative divergence, not a contradiction, reflecting different cohorts and CKD definitions.
DOI:10.3389/fmed.2023.1099840

Bartter syndrome is a rare inherited disorder with a population prevalence on the order of ~1 per 100,000.

CONFLICT LEAD
epidemiology
ProviderStanceScoreEvidence
falcon CONCORDANT 80% A 2023 multicenter cohort review text states a prevalence estimate of approximately
Falcon cites a prevalence estimate of approximately ~1 in 100,000, matching the harmonized figure.
DOI:10.3389/fmed.2023.1099840
openscientist CONTRADICTORY 30% Estimated at 1–2 per 1,000,000 (Orphanet)
OpenScientist gives an Orphanet-based prevalence of 1-2 per 1,000,000 and calls BS ultra-rare — roughly ten-fold lower than Falcon's ~1 per 100,000, a genuine numeric conflict.
The two reports disagree on the prevalence figure by roughly an order of magnitude; the rarity is agreed but the numeric estimate is unresolved and kept as a lead.

Despite characteristic normotension, chronic hypokalemia and hypomagnesemia in Bartter syndrome predispose to ventricular arrhythmias, syncope, and sudden cardiac death, so the disorder is not purely benign.

SINGLE LEAD
phenotypecomorbidity
ProviderStanceScoreEvidence
openscientist CONCORDANT 90% Chronic hypokalemia and hypomagnesemia predispose to ventricular arrhythmias, syncope, and sudden cardiac death, despite the absence of hypertension
OpenScientist devotes a dedicated finding to cardiovascular risk (arrhythmia, syncope, sudden cardiac death) despite normotension.
PMID:39445629
falcon SILENT —
Falcon's report does not address cardiovascular complications, arrhythmia, or sudden cardiac death in Bartter syndrome.

Narrative

Overview

Both providers frame Bartter syndrome as a group of rare, mostly autosomal-recessive (with one X-linked MAGED2 form) salt-losing tubulopathies caused by loss-of-function defects in thick-ascending-limb ion transporters (NKCC2/SLC12A1, ROMK/KCNJ1, ClC-Kb/CLCNKB, barttin/BSND) and the MAGED2 regulator. The shared mechanistic spine runs from impaired TAL NaCl reabsorption through volume depletion and RAAS activation to hypokalemic hypochloremic metabolic alkalosis with normal-to-low blood pressure.

Agreement

The reports converge strongly on the core definition and biochemistry, the five-gene contemporary classification and TAL transporter functions, the ER-retention/ERAD quality-control defect of NKCC2 in the severe type-5 form, the transient-yet-severe nature of the MAGED2 X-linked antenatal form, symptomatic treatment with COX inhibition plus lifelong electrolyte supplementation, and CKD as a significant long-term complication driven by type I and prematurity.

Divergence

OpenScientist is broader and more quantitative on downstream clinical burden — developing the COX-2/PGE2 macula-densa mechanism explicitly, quantifying the MAGED2 outcome (32% perinatal fatality), and adding a cardiovascular-risk thread (ventricular arrhythmia, syncope, sudden cardiac death) that Falcon does not cover at all. Falcon contributes deeper genotype/cohort detail (Korean CLCNKB founder allele, mouse and cattle models, chaperone rescue). The one genuine conflict is prevalence: Falcon cites ~1 per 100,000 while OpenScientist cites an Orphanet figure of 1-2 per 1,000,000; the CKD rate also differs (Falcon's 11% cohort G3-G5 vs OpenScientist's ~30% aggregate), a quantitative rather than qualitative gap.

Integration

Integrated concepts: the TAL-salt-wasting definition and biochemical triad; the five-gene classification with AR/X-linked inheritance and TAL transporter functions; the COX-2/PGE2-hyperreninemia mechanism underpinning indomethacin therapy; NKCC2 ER-retention/ERAD in the severe MAGED2 form; the transient-severe MAGED2 natural history; COX-inhibitor plus electrolyte-supplementation management; and CKD as a long-term complication.

Not integrated (leads)

The order-of-magnitude prevalence estimate was retained as an unresolved lead rather than promoted, and the single-provider cardiovascular-risk (arrhythmia/sudden cardiac death) thread was kept as a research lead pending a second corroborating source.

Cross-provider synthesis of two independent Bartter syndrome deep-research reports: falcon (Edison Scientific Literature, pathophysiology/cohort-focused) and openscientist (comprehensive 15-domain). Nine harmonized findings exercise CONCORDANT, PARTIAL, CONTRADICTORY, and SILENT stances. The only direct contradiction is the prevalence figure; other divergences are coverage or quantitative (CKD rate, MAGED2 outcome quantification, cardiovascular risk). best_matching_text values are verbatim excerpts from the cited report files; literature evidence snippets were intentionally left for the main curation pipeline to verify.